However, there was an increased number of mutated BRAF/MEK/PI3K samples (352) within the MSS CRC, which has a poor prognosis compared to the MSI-H (93 samples) (Figure 6E) [41,42,43]. This evidence concerns the gene MAP2K7 and colorectal carcinoma.